Matthew Davidson

Matthew Davidson

Chief Executive Officer at ADIAL PHARMACEUTICALS, INC.

Net worth: 338 612 $ as of 29/09/2026

42 year
Health Technology
Consumer Services

Profile

Dr. Matthew Davidson is a President, Chief Executive Officer & Director at Adial Pharmaceuticals, Inc. and a President, Chief Executive & Financial Officer at Azora Therapeutics, Inc. He is on the Board of Directors at Adial Pharmaceuticals, Inc. Dr. Davidson was previously employed as a Chief Scientific Officer & Director by Verrica Pharmaceuticals, Inc. He received his undergraduate degree from the University of California, Berkeley and a doctorate degree from Stanford University School of Medicine.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
16/08/2026 84,442 ( 3.22% ) 338 612 $ 29/09/2026

Matthew Davidson active positions

CompaniesPositionStart
ADIAL PHARMACEUTICALS, INC. Chief Executive Officer 27/10/2026
Chief Executive Officer 28/02/2019

Former positions of Matthew Davidson

Education of Matthew Davidson

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

15

1st degree connections

5

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies5

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Matthew Davidson